U.S.
Smirking Martin Shkreli refuses to answer questions
Shkreli's decision not to testify and his reactions infuriated Committee members who released him after 10 minutes
Shkreli's decision not to testify and his reactions infuriated Committee members who released him after 10 minutes
Accused of defrauding investors and gauging patients, Shkreli invokes right to remain silent at hearing on drug prices
Exclusive: GOP candidate was paid by Merck at a time when anti-abortion groups criticized company's vaccine production
House Committee on Oversight and Government Reform has demanded that Martin Shkreli appear at a hearing on drug prices
As drug prices skyrocket, CEO Mark Baum argues that it’s possible to maximize profits and still look out for patients
Federal authorities are facilitating a proxy war between doctors and pharmacists, and patients are caught in the middle
In part 8 of ‘America left behind,’ Al Jazeera looks at the human impact of skyrocketing prescription drug prices
One CEO says there are ways to spare consumers staggering drug costs like the 5,000 percent hike on Daraprim
CEO of Turing Pharmaceuticals sparked controversy after raising price of HIV drug Daraprim to $750 a tablet from $13.50
The WHO's pay-to-play regulatory system inhibits innovation, critics say, exposing fault lines in global public health
